A review of psychological and pharmacological treatment options for methamphetamine dependence

References

• Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006). Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence, 81(3), 313–322.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. (2007). Alcohol and other drug treatment services in Australia 2005–06: Report on the National Minimum Data Set (AIHW cat. no. HSE 53). Canberra: Australian Institute of Health and Welfare.
   Google Scholar
• Baker, A., Boggs, T. G., & Lewin, T. J. (2001). Randomized controlled trial of brief cognitive-behavioural interventions among regular users of amphetamine. Addiction, 96(9), 1279–1287.
   PubMedGoogle Scholar
• Baker, A., Bucci, S., Lewin, T. J., Kay-Lambkin, F., Constable, P. M., & Carr, V. J. (2006). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. British Journal of Psychiatry, 188(5), 439–448.
   PubMed Web of Science ®Google Scholar
• Baker, A., Gowing, L., Lee, N., & Proudfoot, H. (2004). Psychosocial interventions. In A. Baker, N. Lee, & L. Jenner ( Eds.), Models of intervention and care for psychostimulant users. National Drug Strategy Monograph Series No. 51 ( pp. 63–84). Canberra: Commonwealth of Australia.
   Google Scholar
• Baker, A., & Lee, N. K. (2003). A review of psychosocial interventions for amphetamine use. Drug and Alcohol Review, 22(3), 323–335.
   PubMed Web of Science ®Google Scholar
• Baker, A., Lee, N. K., Claire, M., Lewin, T. J., Grant, T., Pohlman, S., Saunders, J. B., Kay-Lambkin, F., Constable, P., Jenner, L., & Carr, V. J. (2005). Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction, 100(3), 367–378.
   PubMed Web of Science ®Google Scholar
• Batki, S. L., Moon, J., Delucchi, K., Bradley, M., Hersh, D., Smolar, S., Mengis, M., Lefkowitz, E., Sexe, D., Morello, L., Everhart, T., Jones, R. T., & Jacob, P. (2000). Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment: Preliminary analysis. Annals of the New York Academy of Sciences, 909, 260–263.
   PubMedGoogle Scholar
• Brodie, J., Figueroa, E., Laska, E., & Dewey, S. (2005). Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse-New York, 55(2), 122–125.
   PubMed Web of Science ®Google Scholar
• Burke, B. L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology, 71(5), 843–861.
   PubMed Web of Science ®Google Scholar
• Carroll, K. M. (1996). Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Experimental and Clinical Psychopharmacology, 4, 46–54.
   Web of Science ®Google Scholar
• Carroll, K. M., Ball, S. A., Nich, C., Martino, S., Frankforter, T. L., Farentinos, C., Kunkel, L. E., Mikulich-Gilbertson, S. K., Morgenstern, J., & Obert, J. L. (2006). Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence, 81(3), 301–312.
   PubMed Web of Science ®Google Scholar
• Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., & Rounsaville, B. J. (2004). Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial. Archives of General Psychiatry, 61(3), 264–272.
   PubMed Web of Science ®Google Scholar
• Cho, A. K., & Melega, W. P. (2002). Patterns of methamphetamine abuse and their consequences. Journal of Addictive Diseases, 21(1), 21–34.
   PubMed Web of Science ®Google Scholar
• Cleary, M., Hunt, G., Matheson, S., & Walter, G. (2009). Psychosocial treatments for people with co-occurring severe mental illness and substance misuse: Systematic review. Journal of Advanced Nursing, 65(2), 238–258.
   PubMed Web of Science ®Google Scholar
• Cogger, S., McKetin, R., Ross, J., & Najman, J. (2008). Methamphetamine treatment evaluation study (MATES): Findings from the Brisbane site ( NDARC Technical Report No. 295). Sydney: National Drug and Alcohol Research Centre.
   Google Scholar
• Crits-Christoph, P., Siqueland, L., Blaine, J., Frank, A., Luborsky, L., Onken, L. S., Muenz, L. R., Thase, M. E., Weiss, R. D., & Gastfried, D. R. (1999). Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Archives of General Psychiatry, 56(6), 493–502.
   PubMed Web of Science ®Google Scholar
• Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O’Brien, C. P. (2004). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology, 30(1), 205–211.
   Google Scholar
• Darke, S., Kaye, S., McKetin, R., & Duflou, J. (2008). Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review, 27(3), 253–262.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Rendle, V., Hall, W., Gilmour, S., & Law, M. (2004). Estimating the number of current regular heroin users in NSW and Australia 1997–2002. National Drug and Alcohol Research Centre (Technical Report No. 198). Sydney: National Drug and Alcohol Research Centre.
   Google Scholar
• Donovan, D. M., Rosengren, D. B., Downey, L., Cox, G. B., & Sloan, K. L. (2001). Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction, 96(8), 1149–1160.
   PubMed Web of Science ®Google Scholar
• Elkashef, A., Vocci, F., Hanson, G., White, J., Wickes, W., & Tiihonen, J. (2008). Pharmacotherapy of methamphetamine addiction: An update. Substance Abuse, 29(3), 31–49.
   PubMed Web of Science ®Google Scholar
• Fechtner, R., Khouri, A., Figueroa, E., Ramirez, M., Federico, M., Dewey, S., & Brodie, J. (2006). Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: Ocular safety pilot results. Archives of Ophthalmology, 124(9), 1257–1262.
   PubMedGoogle Scholar
• Feeney, G. F. X., Connor, J. P., Young, R. M., Tucker, J., & McPherson, A. (2006). Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT). Addictive Behaviors, 31(10), 1833–1843.
   PubMedGoogle Scholar
• French, M. T., Dunlap, L. J., Zarkin, G. A., McGeary, K. A., & McLellan, A. T. (1997). A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment, 14(5), 445–455.
   PubMed Web of Science ®Google Scholar
• Galloway, G. P., Newmeyer, J., Knapp, T., Stalcup, S. A., & Smith, D. (1996). A controlled trial of imipramine for the treatment of methamphetamine dependence. Journal of Substance Abuse Treatment, 13(6), 493–497.
   PubMed Web of Science ®Google Scholar
• Gowing, L., Proudfoot, H., Henry-Edwards, S., & Teesson, M. (2001). Evidence supporting treatment: The effectiveness of interventions for illicit drug use. Canberra: Australian National Council on Drugs.
   Google Scholar
• Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004). Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors, 29(7), 1439–1464.
   PubMed Web of Science ®Google Scholar
• Heinzerling, K., Shoptaw, S., Peck, J., Yang, X., Liu, J., Roll, J., & Ling, W. (2006). Randomized placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 85(3), 177–184.
   PubMed Web of Science ®Google Scholar
• Hubbard, R. L., Craddock, S. G., & Anderson, J. (2003). Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). Journal of Substance Abuse Treatment, 25(3), 125–134.
   PubMed Web of Science ®Google Scholar
• Jaffe, A., Shoptaw, S., Stein, J. A., Reback, C. J., & Rotheram-Fuller, E. (2007). Depression ratings, reported sexual risk behaviors, and methamphetamine use: Latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. Experimental and Clinical Psychopharmacology, 15(3), 301–307.
   PubMed Web of Science ®Google Scholar
• Johnson, B., Roache, J., Ait-Daoud, N., Wells, L., Wallace, C., Dawes, M., Liu, L., & Wang, X. (2007a). Effects of acute topiramate dosing on methamphetamine-induced subjective mood. International Journal of Neuropsychopharmacology, 10(1), 85–98.
   PubMedGoogle Scholar
• Johnson, B., Roache, J., Ait-Daoud, N., Wells, L., Wallace, C., Dawes, M., Liu, L., & Wang, X. (2007b). Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Progress in Neuropsychopharmacology and Biological Psychiatry, 31(1), 123–130.
   PubMed Web of Science ®Google Scholar
• Kelly, E., McKetin, R., & McLaren, J. (2005). Health service utilisation among regular methamphetamine users. Sydney: National Drug and Alcohol Research Centre.
   Google Scholar
• Kirby, K. C., Marlowe, D. B., Festinger, D. S., Lamb, R. J., & Platt, J. J. (1998). Schedule of voucher delivery influences initiation of cocaine abstinence. Journal of Consulting and Clinical Psychology, 66(5), 761–767.
   PubMed Web of Science ®Google Scholar
• Knapp, W. P., Soares, B., Farrell, M., & Silva de Lima, M. (2007). Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews, (3), art. no.: CD003023. doi: 10.1002/14651858.CD003023.pub2.
   Google Scholar
• Kongsakon, R., Papadopoulos, K. I., & Saguansiritham, R. (2005). Mirtazapine in amphetamine detoxification: A placebo-controlled pilot study. International Clinical Psychopharmacology, 20(5), 253–256.
   PubMed Web of Science ®Google Scholar
• Kosten, T. R., Rosen, M., Bond, J., Settles, M., Roberts, J. S. C., Shields, J., Jack, L., & Fox, B. (2002). Human therapeutic cocaine vaccine: Safety and immunogenicity. Vaccine, 20(7–8), 1196–1204.
   PubMed Web of Science ®Google Scholar
• Lam, J. A., Jekel, J. F., Thompson, K. S., Leaf, P. J., Hartwell, S. W., & Florio, L. (1995). Assessing the value of a short-term residential drug treatment program for homeless men. Journal of Addictive Diseases, 14(4), 12–39.
   Google Scholar
• Laqueille, X., Dervaux, A., El Omari, F., Kanit, M., & Baylé, F. J. (2005). Methylphenidate effective in treating amphetamine abusers with no other psychiatric disorder. European Psychiatry, 20(5–6), 456–457.
   PubMedGoogle Scholar
• Lee, N., & Rawson, R. (2008). A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug and Alcohol Review, 27(3), 309–317.
   PubMed Web of Science ®Google Scholar
• Ling, W., Rawson, R., & Shoptaw, S. (2006). Management of methamphetamine abuse and dependence. Current Psychiatry Reports, 8(5), 345–354.
   PubMedGoogle Scholar
• Maglione, M., Chao, B., & Anglin, D. (2000a). Residential treatment of methamphetamine users: Correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994–1997. Addiction Research, 8(1), 65–79.
   Web of Science ®Google Scholar
• Maglione, M., Chao, B., & Anglin, M. D. (2000b). Correlates of outpatient drug treatment drop-out among methamphetamine users. Journal of Psychoactive Drugs, 32(2), 221–228.
   PubMed Web of Science ®Google Scholar
• Marlatt, G. A., & Gordon, J. R. (1985). Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. New York, NY: Guilford Press.
   Google Scholar
• Marlowe, D. B., Kirby, K. C., Festinger, D. S., Merikle, E. P., Tran, G. Q., & Platt, J. J. (2003). Day treatment for cocaine dependence incremental utility over outpatient counseling and voucher incentives. Addictive Behaviors, 28(2), 387–398.
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., & Darke, S. (1995). Drug replacement treatments: Is amphetamine substitution a horse of a different colour? Drug and Alcohol Review, 14(4), 389–394.
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Digiusto, E., Doran, C., O’Brien, S., Shanahan, M., Kimber, J., Henderson, N., Breen, C., Shearer, J., & Gates, J. (2001). National evaluation of pharmacotherapies for opioid dependence (NEPOD): Report of results and recommendations. Canberra: Commonwealth Department of Health and Ageing.
   Google Scholar
• Maude-Griffin, P., Hohenstein, J., Humfleet, G., Reilly, P., Tusel, D., & Hall, S. (1998). Superior efficacy of cognitive-behavioural therapy for urban crack cocaine abusers: Main and matching controls. Journal of Consulting and Clinical Psychology, 66, 832–837.
   PubMed Web of Science ®Google Scholar
• McElhiney, M. C., Rabkin, J. G., Rabkin, R., & Nunes, E. V. (2009). Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: A pilot study. American Journal of Drug and Alcohol Abuse, 35(1), 34–37.
   PubMed Web of Science ®Google Scholar
• McKetin, R., & Kelly, E. (2007). Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug and Alcohol Review, 26(2), 161–168.
   PubMed Web of Science ®Google Scholar
• McKetin, R., Kelly, E., & Indig, D. (2005a). The characteristics of treatment provided for amphetamine use in New South Wales, Australia. Drug and Alcohol Review, 24(5), 433–436.
   PubMed Web of Science ®Google Scholar
• McKetin, R., McLaren, J., Kelly, E., Hall, W., & Hickman, M. (2005b). Estimating the number of regular and dependent methamphetamine users in Australia. Sydney: National Drug and Alcohol Research Centre.
   Google Scholar
• Milby, J. B., Schumacher, J. E., McNamara, C., Wallace, D., Usdan, S., McGill, T., & Michael, M. (2000). Initiating abstinence in cocaine abusing dually diagnosed homeless persons. Drug and Alcohol Dependence, 60(1), 55–67.
   PubMed Web of Science ®Google Scholar
• Milby, J. B., Schumacher, J. E., Wallace, D., Frison, S., McNamara, C., Usdan, S., & Michael, M. (2003). Day treatment with contingency management for cocaine abuse in homeless persons: 12-month follow-up. Journal of Consulting and Clinical Psychology, 71(3), 619–621.
   PubMed Web of Science ®Google Scholar
• Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York, NY: Guilford Press.
   Google Scholar
• Montana Department of Justice. (2009). The economic cost of methamphetamine use in Montana: A report prepared for the office of the attorney general. Retrieved June 1, 2009, from http://www.methproject.org/documents/MT DOJ Cost of Meth in Montana Report.pdf
   Google Scholar
• National Centre in HIV Epidemiology and Clinical Research. (2005). Australian NSP Survey National Data Report 2000-2004. Sydney: University of New South Wales.
   Google Scholar
• Newton, T. F., Roache, J. D., De La Garza, R., Fong, T., Wallace, C. L., Li, S. H., Elkashef, A., Chiang, N., & Kahn, R. (2006). Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology, 31(7), 1537–1544.
   PubMed Web of Science ®Google Scholar
• Nicosia, N., Pacula, R. L., Kilmer, B., Lundberg, R., & Chiesa, J. (2009). The economic cost of methamphetamine use in the United States, 2005. Santa Monica, CA: RAND.
   Google Scholar
• Peck, J. A., Reback, C. J., Yang, X. W., Rotheram-Fuller, E., & Shoptaw, S. (2005). Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men. Journal of Urban Health, 82(Suppl. 1), 100–108.
   Web of Science ®Google Scholar
• Peirce, J. M., Petry, N. M., & Stitzer, M. L. (2006). Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network Study. Archives of General Psychiatry, 63(2), 201–208.
   PubMed Web of Science ®Google Scholar
• Petry, N. M., Peirce, J. M., Stitzer, M. L., Blaine, J., Roll, J. M., Cohen, A., Obert, J., Killeen, T., Saladin, M. E., Cowell, M., Kirby, K. C., Sterling, R., Royer-Malvestuto, C., Hamilton, J., Booth, R. E., Macdonald, M., Liebert, M., Rader, L., Burns, R., DiMaria, J., Copersino, M., Stabile, P. Q., Kolodner, K., & Li, R. (2005). Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A National Drug Abuse Treatment Clinical Trials Network Study. Archives of General Psychiatry, 62(10), 1148–1156.
   PubMed Web of Science ®Google Scholar
• Piasecki, M. P., Steinagel, G. M., Thienhaus, O. J., & Kohlenberg, B. S. (2002). An exploratory study: The use of paroxetine for methamphetamine craving. Journal of Psychoactive Drugs, 34(3), 301–304.
   PubMed Web of Science ®Google Scholar
• Rawson, R. A., Anglin, M. D., & Ling, W. (2002a). Will the methamphetamine problem go away? Journal of Addictive Diseases, 21(1), 5–19.
   PubMed Web of Science ®Google Scholar
• Rawson, R. A., Gonzales, R., & Brethen, P. (2002b). Treatment of methamphetamine use disorders: An update. Journal of Substance Abuse Treatment, 23(2), 145–150.
   PubMed Web of Science ®Google Scholar
• Rawson, R. A., Marinelli-Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., & McCann, M. J. (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99(6), 708–717.
   PubMed Web of Science ®Google Scholar
• Rawson, R. A., McCann, M. J., Flammino, F., Shoptaw, S., Miotto, K., Reiber, C., & Ling, W. (2006). A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction, 101(2), 267–274.
   PubMed Web of Science ®Google Scholar
• Roehr, B. (2005). Half a million Americans use methamphetamine every week. [News]. British Medical Journal, 331(7515), 476.
   PubMedGoogle Scholar
• Roll, J. M., Petry, N. M., Stitzer, M. L., Brecht, M. L., Peirce, J. M., McCann, M. J., Blaine, J., MacDonald, M., DiMaria, J., Lucero, L., & Kellogg, S. (2006). Contingency management for the treatment of methamphetamine use disorders. American Journal of Psychiatry, 163(11), 1993–1999.
   PubMed Web of Science ®Google Scholar
• Rose, M. E., & Grant, J. E. (2008). Pharmacotherapy for methamphetamine dependence: A review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Annals of Clinical Psychiatry, 20(3), 145–155.
   PubMed Web of Science ®Google Scholar
• Sattar, S., Bhatia, S., & Petty, F. (2004). Potential benefits of quetiapine in the treatment of substance dependence disorders. Journal of Psychiatry and Neurosciences, 29(6), 452–457.
   PubMed Web of Science ®Google Scholar
• Schumacher, J. E., Mennemeyer, S. T., Milby, J. B., Wallace, D., & Nolan, K. (2002). Costs and effectiveness of substance abuse treatments for homeless persons. Journal of Mental Health Policy and Economics, 5(1), 33–42.
   PubMedGoogle Scholar
• Shearer, J. (2007). Psychosocial approaches to psychostimulant dependence: A systematic review. Journal of Substance Abuse Treatment, 32(1), 41–52.
   PubMed Web of Science ®Google Scholar
• Shearer, J., & Gowing, L. (2004). Pharmacological interventions. In A. Baker, N. Lee, & L. Jenner ( Eds.), Models of intervention and care for psychostimulant users. NDS Monograph Series No. 51 (2nd ed.). Canberra: Commonwealth of Australia.
   Google Scholar
• Shearer, J., Sherman, J., Wodak, A., & van Beek, I. (2002). Substitution therapy for amphetamine users. Drug and Alcohol Review, 21(2), 179–185.
   PubMed Web of Science ®Google Scholar
• Shoptaw, S., Huber, A., Peck, J., Yang, X., Liu, J., Dang, J., Roll, J., Shapiro, B., Rotheram-Fuller, E., & Ling, W. (2006a). Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 85(1), 12–18.
   PubMed Web of Science ®Google Scholar
• Shoptaw, S., Klausner, J. D., Reback, C. J., Tierney, S., Stansell, J., Hare, C. B., Gibson, S., Siever, M., King, W. D., Kao, U., & Dang, J. (2006b). A public health response to the methamphetamine epidemic: The implementation of contingency management to treat methamphetamine dependence. BMC Public Health, 6, 214.
   PubMed Web of Science ®Google Scholar
• Shoptaw, S., Reback, C. J., Peck, J. A., Yang, X., Rotheram-Fuller, E., Larkins, S., Veniegas, R. C., Freese, T. E., & Hucks-Ortiz, C. (2005). Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence, 78(2), 125–134.
   PubMed Web of Science ®Google Scholar
• Shoptaw, S., Yang, X., Rotheram-Fuller, E. J., Hsieh, Y. C. M., Kintaudi, P. C., Charuvastra, V. C., & Ling, W. (2003). Randomized placebo-controlled trial of baclofen for cocaine dependence: Preliminary effects for individuals with chronic patterns of cocaine use. Journal of Clinical Psychiatry, 64(12), 1440–1448.
   PubMedGoogle Scholar
• Simpson, D. D., Joe, G. W., & Broome, K. M. (2002). A national 5-year follow-up of treatment outcomes for cocaine dependence. Archives of General Psychiatry, 59(6), 538–544.
   PubMed Web of Science ®Google Scholar
• Simpson, D. D., Joe, G. W., Fletcher, B. W., Hubbard, R. L., & Anglin, M. D. (1999). A national evaluation of treatment outcomes for cocaine dependence. Archives of General Psychiatry, 56(6), 507–514.
   PubMed Web of Science ®Google Scholar
• United Nations Office for Drug Control and Crime Prevention. (2000). World drug report. New York, NY: Oxford University Press.
   Google Scholar
• United Nations Office on Drugs and Crime. (2009). World drug report. Geneva: United Nations Publications.
   Google Scholar
• US Department of Health and Human Services. (2005). Methamphetamine use, abuse and dependence: 2002, 2003 and 2004. Retrieved September 15, 2009, from http://oas.samhsa.gov/2k5/meth/meth.pdf
   Google Scholar
• Wachtel, S. R., Ortengren, A., & Wit, H. (2002). The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug and Alcohol Dependence, 68(1), 23–33.
   PubMedGoogle Scholar
• Williamson, A., Darke, S., Ross, J., & Teesson, M. (2006). The association between cocaine use and short-term outcomes for the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review, 25(2), 141–148.
   PubMed Web of Science ®Google Scholar
• Yen, C. F., Wu, H. Y., Yen, J. Y., & Ko, C. H. (2004). Effects of brief cognitive-behavioral interventions on confidence to resist the urges to use heroin and methamphetamine in relapse-related situations. Journal of Nervous and Mental Disease, 192(11), 788–791.
   PubMedGoogle Scholar
• Zweben, A., & Zuckoff, A. (2002). Motivational interviewing and treatment adherence. In W. R. Miller & S. Rollnick ( Eds.), Motivational interviewing: Preparing people for change ( pp. 299–319). New York, NY: Guilford Press.
   Google Scholar